Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedJan 30, 2026
DataAggregated Company Financials
Companies15
- 7D0.3%
- 3M8.1%
- 1Y-8.9%
- YTD-2.1%
Last week, the Biotech industry hasn't moved much but Darwin is up 30% in that time. As for the longer term, the industry has declined 8.9% in the last year. Looking forward, earnings are forecast to grow by 62% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 31 Jan 2026 | €3.4b | €744.1m | -€183,503,342.32 | 4.7x | -18.4x | 4.5x |
| Mon, 29 Dec 2025 | €3.3b | €744.0m | -€183,339,974.59 | 3.7x | -18x | 4.4x |
| Wed, 26 Nov 2025 | €3.2b | €748.0m | -€195,487,687.43 | 3.4x | -16.2x | 4.2x |
| Fri, 24 Oct 2025 | €3.2b | €755.4m | -€211,487,310.00 | 3.5x | -15.1x | 4.2x |
| Sun, 21 Sep 2025 | €2.0b | €121.3m | -€184,032,479.58 | 4x | -10.9x | 16.5x |
| Tue, 19 Aug 2025 | €3.4b | €756.4m | -€228,376,217.71 | 3.5x | -15x | 4.5x |
| Thu, 17 Jul 2025 | €2.3b | €770.0m | -€181,481,492.00 | 3.9x | -12.8x | 3x |
| Sat, 14 Jun 2025 | €882.9m | €137.5m | -€154,499,093.00 | 4.1x | -5.7x | 6.4x |
| Mon, 12 May 2025 | €2.2b | €836.4m | -€146,557,717.00 | 24.1x | -15.2x | 2.7x |
| Wed, 09 Apr 2025 | €2.2b | €818.3m | -€158,890,276.00 | 29.4x | -13.6x | 2.6x |
| Fri, 07 Mar 2025 | €2.2b | €791.9m | €73.0m | 13.8x | 30.5x | 2.8x |
| Sun, 02 Feb 2025 | €2.7b | €791.8m | €74.2m | 14.8x | 36.5x | 3.4x |
| Tue, 31 Dec 2024 | €2.6b | €791.8m | €74.2m | 14.7x | 35.7x | 3.3x |
| Thu, 28 Nov 2024 | €2.6b | €791.8m | €74.2m | 13.4x | 34.5x | 3.2x |
| Sat, 26 Oct 2024 | €2.6b | €866.1m | €170.1m | 11.9x | 15.5x | 3x |
| Mon, 23 Sep 2024 | €2.6b | €867.2m | €174.8m | 11.9x | 14.7x | 3x |
| Wed, 21 Aug 2024 | €2.5b | €868.4m | €171.3m | 13.7x | 14.8x | 2.9x |
| Fri, 19 Jul 2024 | €2.7b | €885.2m | €215.0m | 12.5x | 12.5x | 3x |
| Sun, 16 Jun 2024 | €2.6b | €884.7m | €210.7m | 10.8x | 12.2x | 2.9x |
| Tue, 14 May 2024 | €2.6b | €884.7m | €210.7m | 10x | 12.1x | 2.9x |
| Thu, 11 Apr 2024 | €2.7b | €773.3m | €10.4m | 8.9x | 257.1x | 3.5x |
| Sat, 09 Mar 2024 | €2.6b | €747.5m | -€56,277,837.80 | 11.8x | -46x | 3.5x |
| Mon, 05 Feb 2024 | €2.7b | €769.9m | -€145,885,802.00 | 13.1x | -18.7x | 3.5x |
| Wed, 03 Jan 2024 | €2.9b | €769.9m | -€145,885,802.00 | 13.6x | -19.7x | 3.7x |
| Fri, 01 Dec 2023 | €3.0b | €779.7m | -€160,010,802.00 | 13.7x | -18.6x | 3.8x |
| Sun, 29 Oct 2023 | €3.8b | €955.3m | -€172,995,145.00 | 11.5x | -21.9x | 4x |
| Tue, 26 Sep 2023 | €3.9b | €971.6m | -€197,588,171.00 | 10.8x | -19.6x | 4x |
| Thu, 24 Aug 2023 | €4.1b | €947.8m | -€36,633,772.00 | 19.4x | -111.5x | 4.3x |
| Sat, 22 Jul 2023 | €4.2b | €955.5m | -€219,213,323.00 | 28.3x | -19.2x | 4.4x |
| Mon, 19 Jun 2023 | €4.2b | €967.4m | -€212,883,319.00 | 30x | -19.6x | 4.3x |
| Wed, 17 May 2023 | €3.9b | €967.4m | -€209,726,026.00 | 35.2x | -18.8x | 4.1x |
| Fri, 14 Apr 2023 | €3.6b | €920.1m | -€215,155,012.00 | 13.8x | -16.9x | 3.9x |
| Sun, 12 Mar 2023 | €2.9b | €612.1m | -€74,150,107.00 | 10.1x | -39x | 4.7x |
| Tue, 07 Feb 2023 | €3.1b | €612.1m | -€74,586,900.00 | 11.1x | -41x | 5x |
Price to Earnings Ratio
-41x
Current Industry PE
- Investors are optimistic on the German Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.0x is lower than the industry's current PS ratio of 4.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 6.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -1.70% | |
| Healthcare | -5.84% | |
| Biotech | 0.32% | |
| Biotech | 0.32% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 7V0 Darwin | €10.60 | 20.5% +€21.6m | n/a | PE6.9x | |
| LQ0 Dextech Medical | €1.02 | 30.8% +€4.4m | 226.9% | PS57.5x | |
| PA8K Paion | €0.086 | 560.0% +€519.3k | 436.3% | n/a | |
| 8V8 Genetic Analysis | €0.044 | 4.7% +€138.2k | 111.9% | PS1.6x | |
| T5O bioXXmed | €1.33 | 29.9% +€83.2k | -68.5% | PS17.6x |
